Sky News
Sky News
@skynews·9.3M subscribers·76.1K videos

New Alzheimer's drug is first 'to target the root cause'

Posted

November 30, 2022

Views

23,455

Likes

71

Comments

28

Engagement

0.42%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Kay Burley is joined by Research Information Manager at the Alzheimer's Society, Sian Gregory, who predicted that by 2025 their drug "could benefit at least 106,000 people in the UK".

The new drug called Lecanemab could slow the debilitating symptoms of the disease.

#skynews #alzheimer #medicine

SUBSCRIBE to our YouTube channel for more videos

Follow us on Twitter

Like us on Facebook

Follow us on Instagram

Follow us on TikTok

For more content go to and download our apps

Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí

Sky News videos are also available in German here/Hier können Sie außerdem Sky NewsVideos auf Deutsch finden

To enquire about licensing Sky News content, you can find more information here

Guests & Subjects Covered

Kay BurleyResearch Information ManagerAlzheimer's Society Sian GregoryUK TheTwitter LikeFacebook FollowInstagram FollowTikTok For

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

New Alzheimer's drug is first 'to target the root cause' · Sky News · Sentinel